Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib

por Agwa, Eberechi S, Ma, Patrick C
Publicado 2014

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy

por Lim, Zuan-Fu, Ma, Patrick C.
Publicado 2019

Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

por Oronsky, Bryan, Ma, Patrick C., Morgensztern, Daniel, Carter, Corey A.
Publicado 2017

The Journey of an EGFR-Mutant Lung Adenocarcinoma through Erlotinib, Osimertinib and ABCP Immunotherapy Regimens: Sensitivity and Resistance

por Kibirova, Albina, Mattes, Malcolm D., Smolkin, Matthew, Ma, Patrick C.
Publicado 2019

Durable Near-Complete Response to Anti-PD-1 Checkpoint Immunotherapy in a Refractory Malignant Solitary Fibrous Tumor of the Pleura

por Boothe, James T., Budd, G. Thomas, Smolkin, Matthew B., Ma, Patrick C.
Publicado 2017

Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?

por Albandar, Heidar J., Fuqua, Jacob, Albandar, Jasim M., Safi, Salahuddin, Merrill, Samuel A., Ma, Patrick C.
Publicado 2021

Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma

por Shen, Chan, Holguin, Rolfy A. Perez, Schaefer, Eric, Zhou, Shouhao, Belani, Chandra P., Ma, Patrick C., Reed, Michael F.
Publicado 2022

Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma

por Guo, Tao, Zhao, Shilei, Wang, Peng, Xue, Xiaoyuan, Zhang, Yan, Yang, Mengying, Li, Nan, Li, Zhuoshi, Xu, Lingzhi, Jiang, Lei, Zhao, Lei, Ma, Patrick C., Rosell, Rafael, Li, Jinxiu, Gu, Chundong
Publicado 2023

YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma

por Guo, Tao, Zhao, Shilei, Wang, Peng, Xue, Xiaoyuan, Zhang, Yan, Yang, Mengying, Li, Nan, Li, Zhuoshi, Xu, Lingzhi, Jiang, Lei, Zhao, Lei, Ma, Patrick C., Rosell, Rafael, Li, Jinxiu, Gu, Chundong
Publicado 2017

Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming

por Thiagarajan, Praveena S., Wu, Xiaoliang, Zhang, Wei, Shi, Ivy, Bagai, Rakesh, Leahy, Patrick, Feng, Yan, Veigl, Martina, Lindner, Daniel, Danielpour, David, Yin, Lihong, Rosell, Rafael, Bivona, Trever G., Zhang, Zhenfeng, Ma, Patrick C.
Publicado 2016

AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases

por Wu, Xiaoliang, Ma, Wenjuan, Zhou, Qianghua, Yan, Haijuan, Lim, Zuan-Fu, Huang, Mayan, Deng, Chuangzhong, Yu, Xingsu, Su, Huifang, Komo, Satoshi, Yang, Haixia, Zhang, Xinke, Wen, Sijin, Zhang, Zhenfeng, Ma, Patrick C.
Publicado 2017

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

por Morgensztern, Daniel, Rose, Michal, Waqar, Saiama N., Morris, John, Ma, Patrick C., Reid, Thomas, Brzezniak, Christina E., Zeman, Karen G., Padmanabhan, Arvinda, Hirth, JoAnn, I. Spira, Alexander, Trepel, Jane B, Padda, Sukhmani K.
Publicado 2019

Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing

por Kim, So Yeon, Yin, Jun, Bohlman, Stephen, Walker, Phillip, Dacic, Sanja, Kim, Chul, Khan, Hina, Liu, Stephen V., Ma, Patrick C., Nagasaka, Misako, Reckamp, Karen L., Abraham, Jim, Uprety, Dipesh, Wang, Feng, Xiu, Joanne, Zhang, Jian, Cheng, Haiying, Halmos, Balazs
Publicado 2022

Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC

por He, Yayi, Chen, Linsong, Zhao, Lishu, Dang, Shiying, Liu, Guifeng, Sasada, Shinji, Ma, Patrick C., van Zandwijk, Nico, Rosell, Rafael, Popper, Helmut H., Wang, Hao, Jiang, Minlin, Guo, Haoyue, Liu, Xinyi, Chen, Shifu, Zhang, Xiaoni, Xu, Mingyan, Zhu, Bo, Liu, Ming, Zhou, Caicun
Publicado 2021

Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma

por Chen, Rui, Xia, Wenjia, Wang, Siwei, Xu, Youtao, Ma, Zhifei, Xu, Weizhang, Zhang, Erbao, Wang, Jie, Fang, Tian, Zhang, Quan’an, Dong, Gaochao, Cho, William Chi-shing, Ma, Patrick C., Brandi, Giovanni, Tavolari, Simona, Ujhazy, Peter, Metro, Giulio, Popper, Helmut H., Yin, Rong, Qiu, Mantang, Xu, Lin
Publicado 2019

Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity

por Tang, Zhe, Jiang, Shan, Du, Runlei, Petri, Edward T., El-Telbany, Ahmed, Chan, Perry S.O., Kijima, Takashi, Dietrich, Sascha, Matsui, Kaoru, Kobayashi, Masashi, Sasada, Shinji, Okamoto, Norio, Suzuki, Hideaki, Kawahara, Kunimitsu, Iwasaki, Teruo, Nakagawa, Katsuhiro, Kawase, Ichiro, Christensen, James G., Hirashima, Tomonori, Halmos, Balazs, Salgia, Ravi, Boggon, Titus J., Kern, Jeffrey A., Ma, Patrick C.
Publicado 2008

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities

por Esposito, Roberta, Polidori, Taisia, Meise, Dominik F., Pulido-Quetglas, Carlos, Chouvardas, Panagiotis, Forster, Stefan, Schaerer, Paulina, Kobel, Andrea, Schlatter, Juliette, Kerkhof, Erik, Roemmele, Michaela, Rice, Emily S., Zhu, Lina, Lanzós, Andrés, Guillen-Ramirez, Hugo A., Basile, Giulia, Carrozzo, Irene, Vancura, Adrienne, Ullrich, Sebastian, Andrades, Alvaro, Harvey, Dylan, Medina, Pedro P., Ma, Patrick C., Haefliger, Simon, Wang, Xin, Martinez, Ivan, Ochsenbein, Adrian F., Riether, Carsten, Johnson, Rory
Publicado 2022

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

por Chaib, Imane, Karachaliou, Niki, Pilotto, Sara, Codony Servat, Jordi, Cai, Xueting, Li, Xuefei, Drozdowskyj, Ana, Servat, Carles Codony, Yang, Jie, Hu, Chunping, Cardona, Andres Felipe, Vivanco, Guillermo Lopez, Vergnenegre, Alain, Sanchez, Jose Miguel, Provencio, Mariano, Reguart, Noemi, Zhou, Caicun, Cao, Peng, Ma, Patrick C., Bivona, Trever G., Rosell, Rafael, Chaib, Imane, Karachaliou, Niki, Pilotto, Sara, Servat, Jordi Codony, Cai, Xueting, Li, Xuefei, Drozdowskyj, Ana, Servat, Carles Codony, Yang, Jie, Hu, Chunping, Cardona, Andres Felipe, Vivanco, Guillermo Lopez, Vergnenegre, Alain, Sanchez, Jose Miguel, Provencio, Mariano, de Marinis, Filippo, Passaro, Antonio, Carcereny, Enric, Reguart, Noemi, Campelo, Charo Garcia, Teixido, Cristina, Sperduti, Isabella, Rodriguez, Sonia, Lazzari, Chiara, Verlicchi, Alberto, de Aguirre, Itziar, Queralt, Cristina, Wei, Jia, Estrada, Roger, de la Bellacasa, Raimon Puig, Ramirez, Jose Luis, Jacobsen, Kirstine, Ditzel, Henrik J., Santarpia, Mariacarmela, Viteri, Santiago, Molina, Miguel Angel, Zhou, Caicun, Cao, Peng, Ma, Patrick C., Bivona, Trever G., Rosell, Rafael
Publicado 2017

Activation of the AXL Kinase Causes Resistance to EGFR-Targeted Therapy in Lung Cancer

por Zhang, Zhenfeng, Lee, Jae Cheol, Lin, Luping, Olivas, Victor, Au, Valerie, LaFramboise, Thomas, Abdel-Rahman, Mohamed, Wang, Xiaoqi, Levine, Alan D., Rho, Jin Kyung, Choi, Yun Jung, Choi, Chang-Min, Kim, Sang-We, Jang, Se Jin, Park, Young Soo, Kim, Woo Sung, Lee, Dae Ho, Lee, Jung-Shin, Miller, Vincent A., Arcila, Maria, Ladanyi, Marc, Moonsamy, Philicia, Sawyers, Charles, Boggon, Titus J., Ma, Patrick C., Costa, Carlota, Taron, Miquel, Rosell, Rafael, Halmos, Balazs, Bivona, Trever G.
Publicado 2012